Algernon Pharmaceuticals (AGNPF) Short Interest Ratio & Short Volume $0.06 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Algernon Pharmaceuticals Short Interest DataAlgernon Pharmaceuticals (AGNPF) has a short interest of 30,500 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 18,536 shares to cover all short positions.Current Short Interest30,500 sharesPrevious Short Interest30,500 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1,656.15Short Interest Ratio1.1 Days to CoverLast Record DateMarch 31, 2025Today's Trading Volume0 sharesAverage Trading Volume18,536 sharesToday's Volume Vs. Average0% Short Selling Algernon Pharmaceuticals? Sign up to receive the latest short interest report for Algernon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAGNPF Short Interest Over TimeAGNPF Days to Cover Over TimeAGNPF Percentage of Float Shorted Over Time Algernon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202530,500 shares $1,656.15 No ChangeN/A1.1 $0.05 3/15/202530,500 shares $1,845.25 -1.3%N/A8.2 $0.06 2/28/202530,900 shares $1,940.52 -16.5%N/A2.3 $0.06 2/15/202537,000 shares $2,708.40 +625.5%N/A0.4 $0.07 1/31/20255,100 shares $293.25 +363.6%N/A0.4 $0.06 1/15/20251,100 shares $55.00 No ChangeN/A0.1 $0.05 11/30/20243,000 shares $164.85 No ChangeN/A0.5 $0.05 10/31/20244,200 shares $253.05 -49.4%N/A0.4 $0.06 10/15/20248,300 shares $455.67 No ChangeN/A2 $0.05 9/30/20248,300 shares $559.42 -49.7%N/A0.8 $0.07 Get the Latest News and Ratings for AGNPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Algernon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/202416,500 shares $1,341.78 -0.6%N/A3.8 $0.08 8/31/202416,600 shares $1,328.00 No ChangeN/A1.3 $0.08 8/15/202416,600 shares $1,279.86 -0.6%N/A5.7 $0.08 7/31/202416,700 shares $1,504.67 +4.4%N/A0.6 $0.09 7/15/202416,000 shares $1,472.00 -13.0%N/A6.2 $0.09 6/30/202418,400 shares $1,508.80 +46.0%N/A0.9 $0.08 6/15/202412,600 shares $1,249.16 -58.3%N/A1.4 $0.10 5/31/202430,200 shares $3,473.00 +33.6%N/A1.9 $0.12 5/15/202422,600 shares $2,235.59 -7.8%N/A0.6 $0.10 4/30/202424,500 shares $2,017.33 -40.5%N/A1 $0.08 4/15/202441,200 shares $2,809.84 +34.2%N/A3.1 $0.07 3/31/202430,700 shares $2,517.40 -5.0%N/A4.4 $0.08 3/15/202432,300 shares $2,684.13 +68.2%N/A1.5 $0.08 2/29/202419,200 shares $1,065.60 No ChangeN/A0.3 $0.06 1/15/202440,600 shares $2,541.56 No ChangeN/A1.2 $0.06 12/15/20234,300 shares $259.29 -34.9%N/A0.2 $0.06 11/30/20236,600 shares $421.08 No ChangeN/A0.1 $0.06 7/31/2023800 shares $112.88 +33.3%N/A0.2 $0.14 7/15/2023600 shares $102.00 -95.7%N/A0 $0.17 6/30/202314,100 shares $1,951.44 -45.8%N/A0.5 $0.14 6/15/202326,000 shares $4,420.00 -37.5%N/A0.6 $0.17 5/31/202341,600 shares $6,306.56 +47.5%N/A1.9 $0.15 5/15/202328,200 shares $5,380.56 No ChangeN/A4 $0.19 4/30/202328,200 shares $5,358.00 -14.8%N/A0.9 $0.19 4/15/202333,100 shares $6,130.12 +13.4%N/A1.3 $0.19 3/31/202329,200 shares $5,548.00 +2,333.3%N/A0.7 $0.19 3/15/20231,200 shares $477.00 +50.0%N/A0 $0.40 2/28/2023800 shares $250.00 No ChangeN/A0.2 $0.31 2/15/2023800 shares $1,200.00 No ChangeN/A0.5 $1.50 1/31/2023800 shares $1,245.28 -42.9%N/A0.2 $1.56Trump’s Top Secret $9 Trillion AI Superweapon (Ad)Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit.Nvidia’s early days made millionaires. This AI play might too. 1/15/20231,400 shares $2,352.00 No ChangeN/A0.3 $1.68 12/30/20221,400 shares $2,287.60 -26.3%N/A0.2 $1.63 12/15/20221,900 shares $3,537.80 +18.8%N/A0.5 $1.86 11/30/20221,600 shares $2,896.00 -69.2%N/A0.3 $1.81 11/15/20225,200 shares $11,440.00 +225.0%N/A0.8 $2.20 10/31/20221,600 shares $3,200.00 -23.8%N/A0.2 $2.00 10/15/20222,100 shares $5,000.31 -46.2%N/A0.3 $2.38 9/30/20223,900 shares $11,817.00 -69.1%N/A0.3 $3.03 9/15/202212,600 shares $50,066.10 -28.8%N/A0.5 $3.97 8/31/202217,700 shares $72,570.00 +2,850.0%N/A1.5 $4.10 8/15/2022600 shares $1,899.60 +200.0%N/A0.2 $3.17 7/31/2022200 shares $540.00 -60.0%N/A0 $2.70 7/15/2022500 shares $1,182.50 -87.2%N/A0.3 $2.37 6/30/20223,900 shares $11,349.00 -64.9%N/A1 $2.91 6/15/202211,100 shares $48,618.00 +52.1%N/A2.1 $4.38 5/31/20227,300 shares $30,003.00 No ChangeN/A3 $4.11 3/15/2022100 shares $410.00 No ChangeN/A0 $4.10 2/28/2022100 shares $446.30 No ChangeN/A0 $4.46 1/31/2022500 shares $2,830.00 +150.0%N/A0 $5.66 1/15/2022200 shares $1,344.00 -92.0%N/A0 $6.72 12/31/20212,500 shares $8,275.00 No ChangeN/A0.2 $3.31 11/15/202115,300 shares $79,560.00 +1,175.0%N/A0 $5.20 10/29/20211,200 shares $75.60 +200.0%N/A0 $0.06 10/15/2021400 shares $25.68 -99.3%N/A0 $0.06 9/30/202160,700 shares $4,315.77 +462.0%N/A0.2 $0.07 9/15/202110,800 shares $799.20 +10,700.0%N/A0 $0.07 8/31/2021100 shares $7.75 -100.0%N/A0 $0.08 8/13/2021184,600 shares $18,460.00 +638.4%N/A0.3 $0.10 7/30/202125,000 shares $1,750.00 +101.6%N/A0 $0.07 7/15/202112,400 shares $891.56 -51.9%N/A0 $0.07 6/30/202125,800 shares $2,758.02 +15.2%N/A0 $0.11 6/15/202122,400 shares $2,757.44 -40.6%N/A0 $0.12 5/28/202137,900 shares $5,059.65 -9.1%N/A0.1 $0.13 5/14/202141,700 shares $5,358.45 +24.5%N/A0.1 $0.13 4/30/202133,500 shares $5,025.00 -49.2%N/A0 $0.15 4/15/202165,900 shares $8,507.69 +40.2%N/A0 $0.13 3/31/202147,000 shares $10,885.20 +240.6%N/A0.1 $0.23 3/15/202113,800 shares $3,265.08 -73.7%N/A0 $0.24 2/26/202152,400 shares $14,483.36 No ChangeN/A0 $0.28 1/29/202121,500 shares $4,203.25 +7.5%N/A0 $0.20 1/15/2021178,900 shares $32,508.81 +87.3%N/A0.1 $0.18 12/31/202042,100 shares $7,767.45 -76.5%N/A0 $0.18 12/15/2020178,900 shares $68,339.80 +87.3%N/A0.1 $0.38 11/30/202095,500 shares $18,145.00 +55.5%N/A0.1 $0.19 AGNPF Short Interest - Frequently Asked Questions What is Algernon Pharmaceuticals' current short interest? Short interest is the volume of Algernon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 30,500 shares of AGNPF short. Learn More on Algernon Pharmaceuticals' current short interest. What is a good short interest ratio for Algernon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGNPF shares currently have a short interest ratio of 1.0. Learn More on Algernon Pharmaceuticals's short interest ratio. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Algernon Pharmaceuticals stock? Short selling AGNPF is an investing strategy that aims to generate trading profit from Algernon Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Algernon Pharmaceuticals? A short squeeze for Algernon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AGNPF, which in turn drives the price of the stock up even further. How often is Algernon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGNPF, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies 4Front Ventures Short Interest Data Agentix Short Interest Data Alvotech Short Interest Data Anthera Pharmaceuticals Short Interest Data AstraZeneca Short Interest Data AVVAA World Health Care Products Short Interest Data AXIM Biotechnologies Short Interest Data Bespoke Extracts Short Interest Data BriaCell Therapeutics Short Interest Data Cannabis Global Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:AGNPF) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Algernon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Algernon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGNPF Stock Free AGNPF Stock Alerts